NL-OMON31468
Withdrawn
Not Applicable
Advanced prenatal screening in the first trimester of pregnancy: ADAM12 and PP13 as new screening markers for aneuploidy and adverse pregnancy outcome. - ADAM12 and PP13 in first trimester of pregnancy.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Down syndrome
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 20000
- Status
- Withdrawn
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Pregnant, singleton
- •Between 8\-10 weeks gestation.
Exclusion Criteria
- •Multiple pregnancies.
- •Gestation more than 10 weeks.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Antenatal cytomegalovirus (CMV) screening pilot studyMaternal primary infection with cytomegalovirusReproductive Health and Childbirth - Antenatal careACTRN12623000710628niversity of Melbourne70
Not yet recruiting
Phase 1
A study to diagnose hypertensive disorder of pregnancy in first trimester and to compare its risks in twin and singleton pregnancy.Health Condition 1: O149- Unspecified pre-eclampsiaCTRI/2021/08/035742Kasturba hospital Manipal
Completed
Not Applicable
Reducing False Positives in Prenatal ScreeningPregnancyNCT03375359University Hospital Tuebingen1,127
Completed
Not Applicable
Early Pregnancy Ultrasound Measurements and Prediction of First Trimester Pregnancy Loss.First Trimester AbortionNCT06540092Kasr El Aini Hospital126
Completed
Not Applicable
on-invasive prenatal analysis of pregnancy-course and -outcome by genome-wide RNA sequencingPresymptomatic RNA profiling in pregnancy10026908NL-OMON41926Vrije Universiteit Medisch Centrum2,000